Disruption of RBM20 causes atrial electrophysiological disturbances

preprint OA: closed
📄 Open PDF Full text JSON View at publisher
Full text 2,477 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Background Dilated cardiomyopathy (DCM) is a leading cause of heart failure, with 30–50 % of cases attributed to familial inheritance. Mutations in RNA-binding motif protein 20 (RBM20) account for 3–5 % of cases and are associated with severe DCM and ventricular arrhythmias. However, the role of RBM20 mutations in atrial cardiomyopathy (AtCM) and atrial fibrillation (AF) remains underexplored. This study investigates the effects of the RBM20-R636Q mutation on atrial electrophysiology and evaluates sodium-glucose co-transporter (SGLT) inhibitors as potential therapeutics.

Results

Rbm20-R636Q mice exhibited atrial remodeling, including hypertrophy, left atrial enlargement, and shortened action potential duration at 90% repolarization (APD90). Compared with RBM20-knockout and laminopathy models, RBM20-R636Q mice showed distinct reductions in Ito / IKur without changes in IK,sus or IK,tail currents, alongside TASK-1 potassium current upregulation and alterations of ICaL. SGLT inhibitors (sotagliflozin, empagliflozin, dapagliflozin) reduced AP inducibility and partially restored APD90, with effects comparable to lidocaine, suggesting a role in modulating peak sodium currents.

Conclusions

RBM20 mutations contribute to atrial remodeling, promoting AtCM and AF. SGLT inhibitors demonstrate therapeutic potential by modulating atrial electrophysiology and reducing arrhythmogenesis, offering a promising strategy for managing RBM20-related cardiac disorders. Competing Interest Statement The authors have declared no competing interest. Non-standard Abbreviations and Acronyms - AF - atrial fibrillation - AP - action potential - APD - action potential duration - AtCM - atrial cardiomyopathy - CaMKIIδ - Calcium/Calmodulin-dependent protein kinase II delta - CM - cardiomyocyte - DCM - dilated cardiomyopathy - DMSO - dimethyl sulfoxide - ECG - electrocardiogram - EGTA - ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid - ES - embryonic stem - FVB - Friend leukemia virus B strain - GEO - Gene Expression Omnibus - GWAS - genome-wide association studies - HEPES - 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid - KO - knockout - LA - left atrium - LV - left ventricle - MOPS - 3-morpholinopropane-1-sulfonic acid - RS - arginine-serine - SGLT - sodium-glucose co-transporter - SGLTi - sodium-glucose cotransporter inhibitors - SNP - single nucleotide polymorphism - TEA-Cl - tetraethylammonium chloride - TTN - titin - WT - wild-type

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-20T06:35:16.286784+00:00